Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease

BACKGROUND: We investigated whether combinations of serum cytokines, used with logistic disease predictor models, could facilitate the detection of pancreatic ductal adenocarcinoma (PDAC). METHODS: The serum levels of 27 cytokines were measured in 241 subjects, 127 with PDAC, 49 with chronic pancrea...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Shaw, Victoria E, Lane, Brian, Jenkinson, Claire, Cox, Trevor, Greenhalf, William, Halloran, Christopher M, Tang, Joseph, Sutton, Robert, Neoptolemos, John P, Costello, Eithne
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2014
נושאים:
Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4032456/
https://ncbi.nlm.nih.gov/pubmed/24884871
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-13-114
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים